Temporary Interruption of Endocrine Therapy for Pregnancy, Including Use of Fertility Preservation, Does Not Increase Risk of Breast Cancer Events in Women with HR-positive Breast Cancer By Ogkologos - July 20, 2026 8 0 Facebook Twitter Google+ Pinterest WhatsApp Updated findings from the POSITIVE study Source RELATED ARTICLESMORE FROM AUTHOR Ensartinib Improves DFS Outcomes in Patients with ALK-positive, Completely Resected Stage II to IIIB NSCLC EMA Recommends Extension of Therapeutic Indications for Epcoritamab Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC MOST POPULAR Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ January 8, 2025 EMA Recommends Granting a Marketing Authorisation for Generic Eribulin January 12, 2024 Popular Fitness Blogger Maria Kang Removed Her Breast Implants Due To... August 15, 2019 8-Year-Old Cancer Survivor Celebrates Recovery By Donating Her Birthday Gifts To... July 23, 2019 Load more HOT NEWS FDA Approves Selinexor for Refractory or Relapsed Multiple Myeloma Keeping progress in oncology on the agenda: ESMO honours recipients of... Keanu Reeves Has A Long History Of Supporting Cancer Research How to Safely Keep Up With Your Cancer Screening and Care...
